Hong Kong

Sequencio, a new Hong Kong unit of CK Life Sciences, is advancing about 20 cancer vaccine projects via China's faster pathway to human trials. CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh Kean-meng said the firm plans investigator-initiated trials next year.

29. maaliskuuta 2026 Raportoinut AI

Hong Kong's Secretary for Development Bernadette Linn Hon-ho said dedicated laws for the Northern Metropolis may speed up some projects by about one year. She revealed the government is preparing to increase the residential component of some sites to appeal to developers. The government unveiled a plan for six subsidiary laws earlier this month to remove bottlenecks in the massive scheme.

US importers have cut orders from Hong Kong firms and shifted to short-term contracts amid a global oil crisis triggered by war in the Middle East. Business leaders warn of eroding profit margins and strained liquidity, urging the government to bolster ties with Central Asia and Asean nations to diversify market risks. Executive Council member Jeffrey Lam Kin-fung said the situation will impact SMEs' cash flow.

20. maaliskuuta 2026 Raportoinut AI

InvestHK director general Lau Hai-suen says Hong Kong should leverage its “safe haven for investment” status to attract foreign capital amid Middle East conflict, with firms using Dubai as a hub shifting to the city to diversify risk. The call comes as finance chief Paul Chan Mo-po continues a visit to Beijing.